344 related articles for article (PubMed ID: 10447711)
21. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
Pearson LL; Castle BE; Kehry MR
Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
[TBL] [Abstract][Full Text] [Related]
22. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
[TBL] [Abstract][Full Text] [Related]
23. BRCA1-induced apoptosis involves inactivation of ERK1/2 activities.
Yan Y; Haas JP; Kim M; Sgagias MK; Cowan KH
J Biol Chem; 2002 Sep; 277(36):33422-30. PubMed ID: 12082091
[TBL] [Abstract][Full Text] [Related]
24. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells.
Su JL; Lin MT; Hong CC; Chang CC; Shiah SG; Wu CW; Chen ST; Chau YP; Kuo ML
Carcinogenesis; 2005 Jan; 26(1):1-10. PubMed ID: 15217905
[TBL] [Abstract][Full Text] [Related]
26. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
27. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway.
Goillot E; Raingeaud J; Ranger A; Tepper RI; Davis RJ; Harlow E; Sanchez I
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3302-7. PubMed ID: 9096388
[TBL] [Abstract][Full Text] [Related]
28. The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes.
Rincón M; Whitmarsh A; Yang DD; Weiss L; Dérijard B; Jayaraj P; Davis RJ; Flavell RA
J Exp Med; 1998 Nov; 188(10):1817-30. PubMed ID: 9815259
[TBL] [Abstract][Full Text] [Related]
29. MEK1 activation rescues Jurkat T cells from Fas-induced apoptosis.
Wilson DJ; Alessandrini A; Budd RC
Cell Immunol; 1999 May; 194(1):67-77. PubMed ID: 10357882
[TBL] [Abstract][Full Text] [Related]
30. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
31. Reactive nitrogen species-induced cell death requires Fas-dependent activation of c-Jun N-terminal kinase.
Shrivastava P; Pantano C; Watkin R; McElhinney B; Guala A; Poynter ML; Persinger RL; Budd R; Janssen-Heininger Y
Mol Cell Biol; 2004 Aug; 24(15):6763-72. PubMed ID: 15254243
[TBL] [Abstract][Full Text] [Related]
32. Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes.
Egerton M; Fitzpatrick DR; Kelso A
Int Immunol; 1998 Feb; 10(2):223-9. PubMed ID: 9533450
[TBL] [Abstract][Full Text] [Related]
33. Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis.
Skov S; Klausen P; Claesson MH
J Cell Biol; 1997 Dec; 139(6):1523-31. PubMed ID: 9396757
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of mitogen-activated protein kinase signaling by chloroquine.
Weber SM; Chen JM; Levitz SM
J Immunol; 2002 May; 168(10):5303-9. PubMed ID: 11994488
[TBL] [Abstract][Full Text] [Related]
35. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
MacFarlane M; Cohen GM; Dickens M
Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
[TBL] [Abstract][Full Text] [Related]
36. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors.
Salmon RA; Foltz IN; Young PR; Schrader JW
J Immunol; 1997 Dec; 159(11):5309-17. PubMed ID: 9548470
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
Stadheim TA; Xiao H; Eastman A
Cancer Res; 2001 Feb; 61(4):1533-40. PubMed ID: 11245462
[TBL] [Abstract][Full Text] [Related]
38. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101.
Yazlovitskaya EM; Pelling JC; Persons DL
Mol Carcinog; 1999 May; 25(1):14-20. PubMed ID: 10331740
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase C inhibits CD95 (Fas/APO-1)-mediated apoptosis by at least two different mechanisms in Jurkat T cells.
Ruiz-Ruiz C; Robledo G; Font J; Izquierdo M; López-Rivas A
J Immunol; 1999 Nov; 163(9):4737-46. PubMed ID: 10528172
[TBL] [Abstract][Full Text] [Related]
40. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
